PLoS ONE · 2017 · 80 citations · 21 references
Veterinary MedicineGeneticsMolecular GeneticsCancer GeneticsMolecular OncologyNeoplasiaCancer Cell SignalingMalignant NeoplasmsMalignant TumorsOdontogenic TumorsOncogene MutationsOncogenic Signaling PathwaysBeta-catenin RegulationCancer Mutation AnalysisCanonical Beta-catenin SignalingCystic Odontogenic TumorsNras MutationOdontogenic Cystic LesionsOdontogenic Tumor Molecular PathogenesisTargeted Next-generation Sequencing
Calcifying cystic odontogenic tumors (CCOTs) are benign cystic tumors that form abnormally keratinized ghost cells. Mutations in CTNNB1, which encodes beta-catenin, have been implicated in the development of these tumors, but a causal relationship has not been definitively established. Thus, mutational hot spots in 50 cancer genes were examined by targeted next-generation sequencing in 11 samples of CCOT. Mutations in CTNNB1, but not in other genes, were observed in 10 of 11 cases. These mutations constitutively activate beta-catenin signaling by abolishing the phosphorylation sites Asp32, Ser33, or Ser37, and are similar to those reported in pilomatrixoma and adamantinomatous craniopharyngioma. In contrast, BRAF or NRAS mutations were observed in 12 and two control samples of ameloblastoma, respectively. In HEK293 cells, overexpression of mutated CTNNB1 also upregulated hair keratin, a marker of ghost cells. Furthermore, ghost cells were present in two cases of ameloblastoma with BRAF and CTNNB1 mutations, indicating that ghost cells form due to mutations in CTNNB1. The data suggest that mutations in CTNNB1 are the major driver mutations of CCOT, and that CCOT is the genetic analog of pilomatrixoma and adamantinomatous craniopharyngioma in odontogenic tissue.
21
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin et al. · Nature · 2013 · 4.5K citations · Full text
Pathology and Genetics of Tumours of the Nervous System
Michael Brada · British Journal of Cancer · 2001 · 793 citations · Full text
A common human skin tumour is caused by activating mutations in β-catenin
Edward F. Chan, Uri Gat, Jennifer M. McNiff et al. · Nature Genetics · 1999 · 610 citations
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Robert T. Sweeney, Andrew C. McClary, Benjamin R. Myers et al. · Nature Genetics · 2014 · 361 citations · Full text